Postbiotic and bowel movement regularity
Reduced weekly bowel movements versus placebo in adults with unusually frequent, soft stools.
Scientific Library
The studies, papers and articles that inform how we formulate. Each entry is labelled for what it is: the ingredient it concerns, the type of study and the level of evidence it carries.
Reduced weekly bowel movements versus placebo in adults with unusually frequent, soft stools.
Improved barrier recovery and reduced inflammatory signals in human colon organoid models.
Identified specific probiotic strains with improved overall IBS symptom outcomes.
Combined riboflavin study groups showed increased faecal butyrate production.
Selected coated capsules resisted stomach-like acidity before releasing at intestinal pH.
Stimulated bifidobacteria growth in laboratory and human faecal fermentation cultures.
More participants achieved meaningful IBS symptom relief than with placebo (34% vs 19%).
Human studies consistently associated inulin supplementation with increased bifidobacteria.
Multi-species formulations improved stool frequency, consistency and bloating in pooled trials.
Reduced antibiotic-associated diarrhoea in children in pooled clinical trials.
Increased gut Bifidobacterium and Lactobacillus populations in pooled human studies.
Found beneficial effects on overall IBS symptoms and abdominal pain for selected probiotics.
Review of human studies found that native chicory inulin can increase stool frequency.
Reduced antibiotic-associated diarrhoea risk in pooled trials, with clearer benefit in children.
Increased weekly bowel movements in adults with functional constipation versus placebo.
In adults with constipation, probiotics improved stool frequency, consistency and transit time.
Probiotic supplementation shortened intestinal transit time across adult trials.
Reduced abdominal pain and bloating in adults with IBS versus placebo.
Across pooled clinical trials, probiotics lowered the risk of antibiotic-associated diarrhoea.
Showed that flavins help F. prausnitzii transfer electrons near oxygen in lab models.
Improved overall IBS symptoms, bloating and quality of life versus placebo.
Shortened whole-gut transit time and reduced several digestive symptoms.
Reduced abdominal bloating severity in adults with functional bowel disorders.
Evidence supported riboflavin’s role in maintaining normal mucous membranes and protecting cells from oxidative stress.
Increased Bifidobacterium levels in healthy adults versus placebo.
Shortened recovery by about one day in children with established non-rotavirus diarrhoea.
Improved abdominal discomfort, bloating and bowel symptoms in women with IBS at one tested study level.
Reduced stool frequency more than a live-lactobacilli comparator in chronic diarrhoea.
Shortened acute diarrhoea duration in children receiving oral rehydration therapy.
In a small IBS trial, more favourable composite symptom results occurred with Lacteol Fort than placebo.
Try another ingredient or a broader search.
Know a study we should consider? Get in touch.